Lonza | LONN - Assets


Lonza reported CHF18.97B in Assets for its fiscal semester ending in December of 2025.





Assets Change Date
Akzo Nobel EUR 15.49B 1.53B Mar/2026
Alcon AG USD 31.62B 64M Mar/2026
Almirall EUR 2.34B 29.21M Dec/2025
AstraZeneca USD 114.02B 59M Mar/2026
BASF EUR 76.17B 267M Dec/2025
Bayer EUR 107.94B 3.4B Mar/2026
Beiersdorf EUR 12.76B 166M Dec/2025
Covestro EUR 13.47B 245M Dec/2025
Demant DKK 39.07B 6.43B Dec/2025
Fresenius EUR 41.4B 1.07B Dec/2025
Fresenius Medical Care EUR 31.47B 465.26M Mar/2026
Geberit CHF 3.86B 252.6M Dec/2025
Genmab DKK 12.87B 5.85B Dec/2025
Givaudan CHF 11.86B 587M Dec/2025
GlaxoSmithKline GBP 62.87B 1.75B Mar/2026
GN Store Nord DKK 28.56B 671M Mar/2026
Hikma Pharmaceutical USD 5.67B 117M Dec/2025
Johnson Matthey GBP 5.97B 142M Jun/2026
Merck EUR 53.07B 1.54B Mar/2026
Novartis USD 118.53B 7.58B Mar/2026
Philips EUR 27.27B 322M Mar/2026
Roche Holding CHF 100.7B 5.94B Dec/2025
Sanofi EUR 128.02B 1.22B Mar/2026
Sika AG CHF 15.15B 245M Dec/2025
Smith & Nephew USD 10.69B 150M Dec/2025
Solvay EUR 6.2B 45M Mar/2026
UCB EUR 18.16B 971M Dec/2025